IRIS
ARRIGO, Carmela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 552
EU - Europa 460
AS - Asia 146
AF - Africa 2
Totale 1.160
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 552
IE - Irlanda 147
SE - Svezia 134
CN - Cina 92
UA - Ucraina 57
SG - Singapore 49
DE - Germania 43
FI - Finlandia 21
GB - Regno Unito 20
BE - Belgio 15
CZ - Repubblica Ceca 15
IT - Italia 6
IN - India 5
LV - Lettonia 1
MA - Marocco 1
RU - Federazione Russa 1
SC - Seychelles 1
Totale 1.160
Salva come PNG Salva come JPEG
Città #
Dublin 147
Jacksonville 121
Chandler 113
Nyköping 76
Ann Arbor 52
Beijing 51
Singapore 42
Ashburn 31
Princeton 22
Cambridge 19
Des Moines 16
Brno 15
Brussels 15
Medford 15
Dearborn 14
Woodbridge 10
Lancaster 9
Boardman 8
Wilmington 7
New York 6
Munich 5
Tianjin 5
Los Angeles 4
Norwalk 4
Shenyang 4
Bremen 3
Haikou 3
Hangzhou 3
Hyderabad 3
Jinan 3
Taizhou 3
Washington 3
Changsha 2
Chicago 2
Florence 2
Guangzhou 2
Helsinki 2
Messina 2
Nanchang 2
Pune 2
Seattle 2
Taiyuan 2
Zhengzhou 2
Auburn Hills 1
Clearwater 1
Hebei 1
Hongtong 1
Houston 1
Indianapolis 1
Lanzhou 1
Ningbo 1
Phoenix 1
Qingdao 1
Redwood City 1
San Mateo 1
Santa Clara 1
Weifang 1
Totale 868
Salva come PNG Salva come JPEG
Nome #
CLINICAL ACTIVITY OF BORTEZOMIB IN RELAPSED OR REFRACTORY GASTRIC MARGINAL ZONE B-CELL LYMPHOMA OF MALT TYPE 76
Myelodysplastic syndrome appearing during imatinib mesylate therapy in a patient with GIST 74
HCV genotype 2 as a risk factor for reactivation in patients with B-cell lymphoma undergoing rituximab combination chemotherapy. 72
An acute-leukaemia-like picture due to breast carcinoma cells. 68
Surgical treatment for congestive heart failure with autologous adult stem cell transplantation 68
Effect of treatment with amifostine in patients with myelodisplastic syndromes on clinical outcome and apoptosis in bone marrow 67
Serum concentration of cardiac Troponin T in patients with hypereosinophilic syndrome treated with imatinib is predictive of adverse outcomes 66
Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome with abnormal T cells: a case report 64
Fatal delayed diagnosis in a patient with falciparum malaria 61
Amplification and overexpression of the PSMB5 gene contribute to Bortezomib resistance in re-treatment of patients with Multiple Myeloma 59
Myelodysplastic syndrome/acute myelogenous leukaemia after adjuvant chemotherapy with pyrimidine anti-metabolites in three patients 56
Severe pulmonary complications after bortezomib treatment for multiple myeloma: An unrecognized pulmonary vasculitis? 55
Response to STI571 in chronic myelomonocytic leukemia with platelet derived growth factor beta receptor involvement: a new case report 52
Extramedullary plasmacytoma presented as a non-functional invasive pituitary macro-adenoma. 50
ERLOTINIB IN A PATIENT WITH ACUTE MYELOGENOUS LEUKEMIA AND CONCOMITANT NON-SMALL-CELL LUNG CANCER 50
Salvage therapy for primary central nervous system lymphoma with Y-90-Ibritumomab and Temozolomide 49
Interferon Alpha Has a Strong Anti-tumor Effect in Philadelphia-negative Myeloproliferative Neoplasms 48
Thalidomide treatment of relapsed multiple myeloma patients and changes in circulating VEGF and bFGF 48
DASATINIB INDUCES A RESPONSE IN CHRONIC LYMPHOCYTIC LEUKEMIA 47
How cells respond to interferons. 45
Totale 1.175
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.874
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.874
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020132 0 0 0 0 0 12 26 18 2 47 26 1
2020/2021130 23 0 31 10 2 18 3 16 1 14 7 5
2021/2022165 3 26 4 3 6 1 17 7 2 36 15 45
2022/2023422 29 56 26 22 31 38 5 29 168 2 13 3
2023/202497 8 9 9 22 2 20 0 1 0 5 0 21
2024/202555 6 8 5 31 5 0 0 0 0 0 0 0
Totale 1.175